Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Dermatology

How Common Is CCCA? What Studies Show About Prevalence

At a Glance

Studies suggest that central centrifugal cicatricial alopecia (CCCA) affects about 2.7% to 5.7% of Black women in the populations studied, but the true rate is uncertain because studies use different groups and CCCA may be underrecognized, making the true prevalence uncertain.

Central Centrifugal Cicatricial Alopecia (CCCA) is the most commonly reported primary scarring alopecia among Black women in the available medical literature [1][2]. A primary scarring alopecia is a condition where inflammation directly damages the hair follicle and replaces it with scar tissue.

While exact numbers vary depending on how and where studies are conducted, medical reviews often cite that approximately 2.7% to 5.7% of Black women studied may be affected by this condition [2][3]. Because data comes from specific community and clinical samples, there is no single, definitive prevalence rate that perfectly represents all women of African descent globally. However, if you have recently been diagnosed, it is important to know that you are not alone; this is a widely recognized condition that many Black women navigate.

Making Sense of the Numbers

Estimating exactly how many people have CCCA can be complicated because different studies look at entirely different groups of people. A number that represents people visiting a hair loss specialist cannot be compared to a number representing the general public.

Type of Study Who Was Studied What Was Found What This Means
Medical Reviews Summaries of various studies on Black women An estimated prevalence of 2.7% to 5.7% [2]. This is a general estimate of how common the condition is in the studied populations, though it is not a definitive global rate [2].
Community Screening 326 African American women at community events in Ohio 28% had central hair loss; 59% of those had clinical signs of scarring (roughly 16.5% of the total sample) [4]. This highlights how common clinical signs of central hair loss can be in a specific community, but these were visual screenings, not biopsy-confirmed diagnoses [4].
Biopsy & Clinic Records Patients who already had a scalp biopsy for hair loss CCCA accounted for about 22% of all alopecia diagnoses in a Jamaican biopsy study and a separate retrospective review [5][6]. This shows CCCA is a leading cause of hair loss among people referred to specialists, not that 22% of the general population has it [7].

Why CCCA May Be Underrecognized

Evidence suggests that CCCA may be underrecognized in the general population, meaning the true number of people affected remains uncertain [8]. Several factors contribute to this:

  • Misdiagnosis: In its early stages, CCCA is often mistaken for other types of hair loss, such as traction alopecia (hair loss from tight hairstyles), especially since both conditions can happen at the same time [8].
  • Variable Presentation: While CCCA classically starts at the vertex (the crown or top center of the head) and spreads outward, it can sometimes show up in patchy, frontal, or temporal patterns, making it harder to recognize immediately [9].
  • Barriers to Care: Some patients face challenges in getting an accurate diagnosis due to a lack of clinician experience with both Black hair care and scarring alopecias [10].
  • Delayed Seeking of Care: Because hair thinning happens gradually, many women may try to camouflage the hair loss or seek help from cosmetologists before visiting a dermatologist, delaying an official medical diagnosis [10].

What This Means For You

If you have been diagnosed with CCCA, it is crucial to understand that you did not cause this. The exact causes of CCCA are multifactorial and include genetic components [3]. While specific hairstyles or chemical relaxers can cause irritation or tension, they are not proven to be the single cause of CCCA [11][12].

Because scarring can permanently destroy affected hair follicles, the goal of early evaluation is to identify and stop active inflammation to prevent further loss, rather than to predictably regrow hair in areas that have already scarred [1]. Symptoms like itching, burning, tenderness, scaling, or pustules on the scalp are signs of active inflammation and should prompt an evaluation by your dermatologist [13].

Common questions in this guide

How common is CCCA among Black women?
Medical reviews estimate that about 2.7% to 5.7% of Black women in the studied populations may have CCCA. These figures come from specific studies and should not be treated as a definitive prevalence rate for all women of African descent worldwide.
Does a study finding of 22% mean that 22% of Black women have CCCA?
No. The 22% figure came from biopsy and clinic records and describes the share of alopecia diagnoses among people already referred for hair-loss evaluation, not the general population.
Why are estimates of CCCA prevalence so different?
Studies may examine different groups, such as community participants or people referred to hair-loss specialists, and may use screening rather than biopsy-confirmed diagnoses. CCCA can also be underrecognized or mistaken for traction alopecia, so the true number remains uncertain.
Can hairstyles or chemical relaxers cause CCCA?
Specific hairstyles and chemical relaxers may cause scalp irritation or tension, but they have not been proven to be the single cause of CCCA. The condition appears to have multiple contributing factors, including genetic components.
What symptoms may signal active CCCA?
Itching, burning, scalp tenderness, scaling, or pustules can signal active inflammation. Contact a dermatologist for evaluation, especially if these symptoms occur with central hair thinning or loss.
Can hair grow back after CCCA causes scarring?
Scarring can permanently destroy affected hair follicles, so hair may not predictably regrow in areas that have already scarred. Early evaluation and treatment focus on stopping active inflammation and preventing additional loss.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Central centrifugal cicatricial alopecia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my symptoms, what are the current goals of my treatment—stopping active loss, managing symptoms, or addressing specific areas?
  2. 2.How are you measuring the extent and activity of my CCCA, and what does that assessment mean for my treatment options?
  3. 3.Are there specific signs in my scalp biopsy or exam that confirm this is CCCA rather than, or in addition to, traction alopecia?
  4. 4.What specific signs of active inflammation should I look for at home, and when should I call the office between appointments?

References

References (13)
  1. 1

    Central Centrifugal Cicatricial Alopecia: Challenges and Treatments.

    Lawson CN, Bakayoko A, Callender VD

    Dermatologic clinics 2021; (39(3)):389-405 doi:10.1016/j.det.2021.03.004.

    PMID: 34053593
  2. 2

    Central Centrifugal Cicatricial Alopecia: New Insights and a Call for Action.

    Dlova NC, Salkey KS, Callender VD, McMichael AJ

    The journal of investigative dermatology. Symposium proceedings 2017; (18(2)):S54-S56 doi:10.1016/j.jisp.2017.01.004.

    PMID: 28941495
  3. 3

    Variant PADI3 in Central Centrifugal Cicatricial Alopecia.

    Malki L, Sarig O, Romano MT, et al.

    The New England journal of medicine 2019; (380(9)):833-841 doi:10.1056/NEJMoa1816614.

    PMID: 30763140
  4. 4

    Medical and environmental risk factors for the development of central centrifugal cicatricial alopecia: a population study.

    Kyei A, Bergfeld WF, Piliang M, Summers P

    Archives of dermatology 2011; (147(8)):909-14 doi:10.1001/archdermatol.2011.66.

    PMID: 21482861
  5. 5

    Histopathologic Spectrum of Alopecias Seen in a Jamaican Setting.

    Ho JD, Collie CJ, Spencer SA

    The American Journal of dermatopathology 2023; (45(8)):532-538 doi:10.1097/DAD.0000000000002487.

    PMID: 37377278
  6. 6

    Premature Desquamation of the Inner Root Sheath in Noninflamed Hair Follicles as a Specific Marker for Central Centrifugal Cicatricial Alopecia.

    Tan T, Guitart J, Gerami P, Yazdan P

    The American Journal of dermatopathology 2019; (41(5)):350-354 doi:10.1097/DAD.0000000000001336.

    PMID: 30562220
  7. 7

    Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study.

    Vañó-Galván S, Saceda-Corralo D, Blume-Peytavi U, et al.

    Skin appendage disorders 2019; (5(5)):309-315 doi:10.1159/000496708.

    PMID: 31559256
  8. 8

    Central Centrifugal Cicatricial Alopecia Presenting with Irregular Patchy Alopecia on the Lateral and Posterior Scalp.

    Miteva M, Tosti A

    Skin appendage disorders 2015; (1(1)):1-5 doi:10.1159/000370315.

    PMID: 27172374
  9. 9

    Lessons from a scoping review: Clinical presentations of central centrifugal cicatricial alopecia.

    Sow YN, Jackson TK, Taylor SC, Ogunleye TA

    Journal of the American Academy of Dermatology 2024; (91(2)):259-264 doi:10.1016/j.jaad.2024.03.009.

    PMID: 38521463
  10. 10

    Health care barriers and quality of life in central centrifugal cicatricial alopecia patients.

    Akintilo L, Hahn EA, Yu JMA, Patterson SSL

    Cutis 2018; (102(6)):427-432.

    PMID: 30657802
  11. 11

    Risk factors and comorbidities associated with central centrifugal cicatricial alopecia.

    Green M, Feschuk A, Valdebran M

    International journal of women's dermatology 2023; (9(3)):e108 doi:10.1097/JW9.0000000000000108.

    PMID: 37745896
  12. 12

    Updates on disorders in curly hair.

    Geisler AN, Taye M, Larrondo J, et al.

    International journal of dermatology 2024; (63(9)):1145-1154 doi:10.1111/ijd.17184.

    PMID: 38622785
  13. 13

    Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris Can Look Identical on Histopathology.

    Sun CW, Motaparthi K, Hsu S

    Skinmed 2020; (18(6)):365-366.

    PMID: 33397566

This page summarizes studies about how common CCCA is and explains why prevalence estimates vary. It is for informational purposes only and does not replace advice from a dermatologist about your diagnosis or care.